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Background: The mean age of renal transplant recipients is rising, with age no longer considered a
contraindication. Outcomes in older patients have not, however, been fully defined. The aim of our study is to
evaluate outcomes in older people following renal transplantation at a Scottish regional transplant unit.
Methods: All renal transplants from January 2001 to December 2010 were analysed (n = 762). Outcomes following
renal transplantation in people over 65 years old were compared to those in younger patients. Outcome measures
were: delayed graft function (DGF), primary non-function (PNF), biopsy proven acute rejection (BPAR), serum
creatinine at 1 year and graft and recipient survival. Lengths of initial hospital stay and re-admission rates were also
assessed. Student’s T-Test was used to analyse continuous variables, Pearson’s Chi-Squared test for categorical
variables and the Kaplan-Meier estimator for survival analysis.
Results: Older recipients received proportionately more kidneys from older donors (27.1% vs. 6.3%; p < 0.001).
Such kidneys were more likely to have DGF (40.7% vs. 16.9%; p < 0.001). Graft loss at 1 year was higher in kidneys
from older donors (15.3% vs. 7.6%; p = 0.04). There was no significant difference in patient survival at 1 year based
on the age of the donor kidney. Recipient age did not affect DGF (16.9% vs. 18.5%; p = 0.77) or graft loss at 1 year
(11.9% vs. 7.8%; p = 0.28). Older recipients were, however, more likely to die in the first year post transplant
(6.8% vs. 2.1%; p = 0.03). BPAR was less common in older patients (6.8% vs. 22%; p < 0.01). Older recipients were
more likely to be readmitted to hospital (31.8% vs. 10.9%; p < 0.001).
Conclusions: Older patients experience good outcomes following renal transplantation and donor or recipient age
alone should not preclude this treatment. An awareness of this in clinicians managing older patients is important
since the prevalence of End Stage Renal Disease is increasing in this age group.
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The incidence and prevalence of older patients with End
Stage Renal Disease (ESRD) is increasing, with a median
patient age of 64.9 years at time of diagnosis in the
United Kingdom [1]. Half of patients with ESRD in the
United States are over 65 and one third over 70 years
old when first diagnosed [2]. An awareness of the rela-
tive benefits and risks of treatment options for older pa-
tients with ESRD is therefore increasingly important to
the practicing gerontologist.
The principal modalities of renal replacement therapy
(RRT) for older patients with ESRD are either dialysis* Correspondence: carloceresa@hotmail.com
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reproduction in any medium, provided the or(peritoneal or haemodialysis) or renal transplantation
[3]. The mean age of renal transplant recipients is rising,
with advanced age no longer considered a contraindica-
tion to transplantation. Survival, quality of life and
economic advantages have been demonstrated after
renal transplantation in older patients, including those
with co-morbidities, compared to treatment with dia-
lysis [4-6].
Nevertheless, access to renal transplantation continues
to be limited for older people with ESRD. Improvements
in access have been at best modest in several European
countries including Scotland [7]. Reasons for this may
include organ allocation policy, lack of awareness or
ageism [8,9], with a Canadian study finding thatral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Number of renal transplants performed by age
and proportion of live and cadaveric donor organs used







Less than 45 years old (n=400) 66.5% 33.5%
45 – 64 years old (n=303) 80.9% 19.1%
65 years old or older (n=59) 86.4% 13.6%
Table 2 Aetiologies of renal failure in patients aged over
65 years undergoing renal transplantation
Aetiology of renal failure No. of recipients aged
65 or over (%)
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dications to transplantation were not referred for as-
sessment [10].
Greater definition of outcomes following renal trans-
plantation in patients at the extremes of age would be
beneficial. The primary objective of this study was to
evaluate graft and patient outcomes following renal
transplantation in older donors and recipients.
Methods
Participants
All renal transplants performed from January 2001 to
December 2010 were included in our retrospective cohort
study (n = 762). For the purposes of this study, older
people were defined as aging 65 years or older (n = 59)
and post-transplantation outcomes in this group were
compared to those in younger patients (n = 703).
Outcomes
The outcome measures studied were: delayed graft func-
tion (DGF, defined as the need for dialysis within the
first week following transplantation), primary non-
function (PNF, as defined by failure of the transplanted
kidney to function within the first 6 weeks post-
transplant), biopsy proven acute rejection (BPAR), serum
creatinine at 1 year and graft and recipient survival.
Lengths of initial hospital stay and re-admission rates
were also assessed.
Statistical analysis
Student’s T-Test was used to analyse continuous vari-
ables, Pearson’s Chi-Squared test for categorical variables
and the Kaplan-Meier estimator for survival analysis.
SPSS (version 16) was used for data analysis.
Ethics
Formal ethical approval was not required for this retro-
spective study as it did not affect the management of its
subjects. Approval was obtained from the local Clinical
Effectiveness Department to analyse outcomes.Unknown aetiology 17 (28.8%)
Glomerulonephritis 12 (20.3%)
Other 8 (13.5%)
Obstructive uropathy 5 (8.5%)
IgA nephropathy 4 (6.8%)
Adult polycystic kidney disease 3 (5.1%)
Hypertensive nephropathy 3 (5.1%)
Diabetic nephropathy 2 (3.4%)
Reflux nephropathy 2 (3.4%)
Chronic pyelonephritis 1 (1.7%)
Focal segmental glomerulosclerosis 1 (1.7%)
Congenital hypoplastic kidneys 1 (1.7%)Results
Renal transplantation rate and type of donor organ used
in older transplant recipients
Older people represented a relatively small proportion of
live donor (4.0%) and cadaveric donor (9.1%) renal trans-
plant recipients. 8% of donor organs were from people
aged over 65. The proportion of renal transplants where
cadaveric donor organs were used became greater as re-
cipient age increased, as shown in Table 1. The total
number of renal transplants performed decreased with
age despite an increased prevalence of ESRD in older
people.Demographics and pre-transplant data of older patients
undergoing renal transplantation
Of the 59 patients aged 65 years or over undergoing
transplantation, the median age was 67 (range: 65 – 75).
Thirty seven recipients (62.7%) were male and 22 recipi-
ents were female (37.3%). The aetiology of renal failure
in the older patient population is shown in Table 2.
Forty seven recipients (79.7%) were receiving regular
dialysis prior to transplantation for a median duration of
4 years (range: 0.4 – 20 years). In order to be able to ad-
here to a strict post-operative immunosuppressive drug
regimen, all patients listed for transplantation were
deemed to have a high level of cognitive function.
The association between donor organ Age on outcomes
following renal transplantation
The older recipients who did undergo renal transplant-
ation were more likely to receive organs from older
donors (27.1% vs. 6.3%; p < 0.001). Kidneys from such
donors were more likely to have DGF (40.7% vs. 16.9%;
p < 0.001) and fail in the first year after transplantation
(15.3% vs. 7.6%; p = 0.04). Serum creatinine at 1 year was
also higher in patients who received kidneys from elderly
donors (245 + /−29.3 μmoll/l vs. 176.7 + /−6.7 μmol/l;
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recipient mortality.
The association between recipient Age and outcomes
following renal transplantation
Older renal transplant recipients were less likely than
younger recipients to have BPAR (6.8% vs. 22%; p < 0.01).
There was no difference in the rates of DGF (16.9% vs.
18.5%; p = 0.77) or graft loss at 1 year (11.9% vs.
7.8%; p = 0.28) between older and younger recipients.
Mortality rate in the first year post transplantation was,
however, greater in older patients (6.8% vs. 2.1%; p = 0.03).
The mean length of hospital stay was 7.91 + /−2.49
days. 12.1% of patients were readmitted in the year fol-
lowing renal transplantation. Readmission rates were
higher in older renal transplant recipients (31.8% vs.
10.9%; p < 0.001) but not in the recipients of kidneys
from older donors (18.6% vs. 11.9%; p = 0.32). Length
of initial hospital stay was not affected by donor
(7.87 + /− 2.46 days vs. 7.9+/− 2.78 days, p = 0.73) or re-
cipient (7.9+/−2.48 days vs. 8.0+/−2.68 days, p = 0.846)
age.
Discussion
Older people represent a considerable and increasing
proportion of adults with ESRD. There is growing evi-
dence that such patients, in the absence of contraindica-
tions, have better outcomes after renal transplantation
than alternative forms of RRT [2,11]. Previous research
highlighted that half of patients receiving RRT in the
dialysis units which refer to our transplant unit are aged
65 or over [9]; in this study they represented only 4%
and 9.1% of live and cadaveric donor renal transplant re-
cipients respectively.
Outcomes in those elderly patients who did undergo
renal transplantation were, however, encouraging. Older
transplant recipients were not more likely to have de-
layed graft function or graft loss in the year following
transplantation despite significantly increased usage of
older donor kidneys in older recipients. The length of
initial post-operative stay after transplantation was
not affected by recipient age with the average stay be-
ing 7.9+/−2.48 days in patients aged 65 or over and
8.0 + /−2.68 days in patients aged under 65 (p = 0.846).
Similarly, Fabrizii et al. [12] reported no significant differ-
ence in initial duration of hospital stay between older and
younger patients. Whilst this may appear surprising, one
of the main reasons for a prolonged hospital stay after
renal transplantation is DGF, irrespective of patient age
[13]. We have demonstrated comparable DGF rates in
older and younger recipients. This may account for the
similar durations of hospital stay in the two groups. The
rate of readmission was, however, higher than for younger
recipients and this may have implications for healthcareplanning and service delivery of renal transplantation in
the future, with additional hospital beds and resources al-
located to post-transplantation care of older renal trans-
plant recipients. Nevertheless the quality of life and
economic benefits of transplantation over dialysis (which
generally involves frequent hospital attendance [14,15])
are well recognised and will likely result in overall reduc-
tion in healthcare costs for these patients. Mortality rate
was higher in older transplant recipients, reflecting the
expected increased mortality in this group. It is recognised
that mortality rate in older people with ESRD is lower
when treated with transplantation than alternative forms
of RRT [16].
This study also highlights the significantly reduced rate
of biopsy-proven acute rejection of renal grafts in older
patients. Prevention of rejection is generally easier in
older patients due to natural immunosenescence [17],
allowing reduced dosage of immunosuppressant medica-
tion. Immunosuppressant dose reduction in older renal
transplant recipients has been associated with improved
recipient and graft survival, reduction in cardiovascular
risk, reduced drug side effects and cost savings [18].
Therefore there is increasing evidence that, in the ab-
sence of contra-indications, older people with ESRD are
best treated with renal transplantation and that some
important aspects of post-operative care are less challen-
ging due to natural immunosenescence than for younger
patients. Nevertheless, several factors limit increased
access to transplantation in older patients. These include
organ allocation policies and failure to refer older poten-
tial transplant recipients, although the primary factor
remains insufficient organ availability. With an aver-
age waiting time for a cadaveric kidney in the United
Kingdom of around 4 years, there may be a natural
reluctance to refer older patients with a shorter life ex-
pectancy. Several strategies attempt to address this issue,
including using “extended criteria” organs and the
Eurotransplant Senior Program, a matching scheme which
favours the use of older donor kidneys for older recipients
[19]. As our study demonstrates, outcomes from such
kidneys are inferior to younger kidneys from healthier do-
nors, with increased DGF, graft failure and serum creatin-
ine levels. This is, however, an acceptable compromise if
access to transplantation for older people is improved
since most have a functioning graft at time of death [20]
and there was no association between the use of older
donor organs and mortality in our study.
Another method of increasing access to transplant-
ation involves improving the live donor transplantation
rate. Kidneys from older live donors are not inferior to
those from younger cadaveric donors [21] and spare the
recipient from the morbidity and mortality of dialysis
whilst awaiting transplant – this is considerable, with
the majority of older people on the transplant waiting
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studies have found that older people donating kidneys
for live donor transplantation experience minimal ad-
verse health effects [22-24]. Older people should there-
fore not be discouraged from offering kidneys for live
donor renal transplantation. Given that only 8% of do-
nors in our study were aged over 65, increased aware-
ness of the excellent reported donor and recipient
outcomes following transplantation may increase dona-
tion and improve access to transplantation in the future.
The limitations of this study include its retrospective
nature, so only the association between age and the out-
come measures studied can be calculated and causation
cannot be determined. Furthermore, the relatively low
transplantation rate in older patients reduces the
power of statistical tests to detect small differences in
outcomes.
Conclusions
From our study, we support the fact that fit older people
may offer kidneys for live donor kidney transplantation
with excellent outcomes for both donor and recipient.
We recommend that an increased awareness that older
people with ESRD are best treated by renal transplant-
ation in the absence of contraindications is necessary
amongst all clinicians responsible for treating older
patients.
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